These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15948362)

  • 1. Calprotectin: a predictive marker of a relapse in ulcerative colitis.
    Isselbacher KJ
    Postgrad Med; 2005 May; 117(5):8. PubMed ID: 15948362
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid Fecal Calprotectin Testing Predicts Mucosal Healing Better than C-reactive Protein and Serum Tumor Necrosis Factor α in Patients with Ulcerative Colitis.
    Voiosu T; Benguş A; Bălănescu P; Dinu R; Voiosu A; Băicuş C; Mateescu B
    Rom J Intern Med; 2015; 53(3):253-60. PubMed ID: 26710501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal Healing In Ulcerative Colitis-The Fountain of Youth?
    Cijevschi Prelipcean C; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):747-9. PubMed ID: 30137701
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases.
    Tursi A; Elisei W; Giorgetti G; Picchio M; Brandimarte G
    Scand J Gastroenterol; 2013 Nov; 48(11):1359-60. PubMed ID: 23971760
    [No Abstract]   [Full Text] [Related]  

  • 6. Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
    Theede K; Holck S; Ibsen P; Kallemose T; Nordgaard-Lassen I; Nielsen AM
    Inflamm Bowel Dis; 2016 May; 22(5):1042-8. PubMed ID: 26919460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.
    De Vos M; Dewit O; D'Haens G; Baert F; Fontaine F; Vermeire S; Franchimont D; Moreels T; Staessen D; Terriere L; Vander Cruyssen B; Louis E;
    J Crohns Colitis; 2012 Jun; 6(5):557-62. PubMed ID: 22398050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of faecal calprotectin in ulcerative colitis patients.
    Scaioli E; Scagliarini M; Cardamone C; Liverani E; Ugolini G; Festi D; Bazzoli F; Belluzzi A
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1418-24. PubMed ID: 26308711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal excretion of deoxyribonucleic acid in long-term follow-up of patients with inactive ulcerative colitis.
    Casellas F; Borruel N; Antolín M; Varela E; Torrejón A; Armadans L; Guarner F; Malagelada JR
    Inflamm Bowel Dis; 2007 Apr; 13(4):386-90. PubMed ID: 17206700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
    Tursi A; Elisei W; Giorgetti G; Aiello F; Brandimarte G
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):247-55. PubMed ID: 21769075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin evaluation in patients with ulcerative colitis.
    Dogan T; Agilli M
    Dig Dis Sci; 2015 Apr; 60(4):1109-10. PubMed ID: 25586087
    [No Abstract]   [Full Text] [Related]  

  • 14. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
    Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
    Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Faecal calprotectin in inflammatory bowel disease].
    Sipponen T; Kolho KL
    Duodecim; 2011; 127(24):2631-7. PubMed ID: 22320105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
    Kristensen V; Klepp P; Cvancarova M; Røseth A; Skar V; Moum B
    J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
    Røseth AG; Aadland E; Grzyb K
    Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345
    [No Abstract]   [Full Text] [Related]  

  • 18. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.
    Lasson A; Stotzer PO; Öhman L; Isaksson S; Sapnara M; Strid H
    J Crohns Colitis; 2015 Jan; 9(1):26-32. PubMed ID: 25008478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Cutoff Levels of Fecal Calprotectin to Predict Clinical Relapse in Ulcerative Colitis.
    Scaioli E; Digby RJ; Belluzzi A
    Inflamm Bowel Dis; 2016 Jul; 22(7):E26. PubMed ID: 27271496
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin.
    Casellas F; Borruel N; Torrejón A; Varela E; Antolin M; Guarner F; Malagelada JR
    Aliment Pharmacol Ther; 2007 May; 25(9):1061-7. PubMed ID: 17439507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.